SILEXION THERAPEUTICS CORP Other Nonoperating Income (Expense)
SILEXION THERAPEUTICS CORP (SLXN) reported Other Nonoperating Income (Expense) of -$115.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-14
- SILEXION THERAPEUTICS CORP other nonoperating income (expense) for the quarter ending 2026-06-30 was -$115.00K, a 144.23% decline year-over-year.
- SILEXION THERAPEUTICS CORP other nonoperating income (expense) for the quarter ending 2026-03-31 was $4.00K, a 33.33% increase year-over-year.
- SILEXION THERAPEUTICS CORP other nonoperating income (expense) for the quarter ending 2025-12-31 was $6.00K, a 200.00% increase year-over-year.
- SILEXION THERAPEUTICS CORP other nonoperating income (expense) for the quarter ending 2025-09-30 was $4.00K, a 33.33% increase year-over-year.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$115.00K 10-Q · filed 2026-08-14 | -$99.00K 10-Q · filed 2026-08-14 | -$105.00K derived: sum of 3 quarters · filed 2026-08-14 | -$101.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $4.00K S-1/A · filed 2026-08-10 | $10.00K derived: sum of 2 quarters · filed 2026-08-10 | $14.00K derived: sum of 3 quarters · filed 2026-08-10 | $274.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $6.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $10.00K derived: sum of 2 quarters · filed 2026-08-10 | $270.00K derived: sum of 3 quarters · filed 2026-08-14 | $13.00K S-1/A · filed 2026-08-10 | ||
| 2025-09-30 | $4.00K 10-Q · filed 2025-11-12 | $264.00K derived: sum of 2 quarters · filed 2026-08-14 | $7.00K 10-Q · filed 2025-11-12 | $269.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $260.00K 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2025-08-12 | $336.00K 10-Q · filed 2026-08-14 | $3.00K 10-Q · filed 2025-08-12 | $265.00K derived: sum of 3 quarters · filed 2026-08-14 | $268.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $3.00K S-1/A · filed 2026-08-10 | $5.00K derived: sum of 2 quarters · filed 2026-08-10 | $8.00K derived: sum of 3 quarters · filed 2026-08-10 | $10.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2024-12-31 | $2.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $5.00K derived: sum of 2 quarters · filed 2026-08-10 | $7.00K derived: sum of 3 quarters · filed 2026-08-10 | $7.00K S-1/A · filed 2026-08-10 | ||
| 2024-09-30 | $3.00K 10-Q · filed 2025-11-12 | $5.00K derived: sum of 2 quarters · filed 2025-11-12 | $5.00K 10-Q · filed 2025-11-12 | $6.00K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $2.00K 10-Q · filed 2025-08-12 | $2.00K 10-Q · filed 2025-08-12 | $3.00K derived: sum of 3 quarters · filed 2025-08-20 | $4.00K derived: sum of 4 quarters · filed 2025-08-20 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-13 | $1.00K derived: sum of 2 quarters · filed 2025-08-20 | $2.00K derived: sum of 3 quarters · filed 2025-08-20 | $5.00K derived: sum of 4 quarters · filed 2025-08-20 | ||
| 2023-12-31 | $1.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-08-20 | $2.00K derived: sum of 2 quarters · filed 2025-08-20 | $5.00K derived: sum of 3 quarters · filed 2025-08-20 | $6.00K 8-K · filed 2025-08-20 | ||
| 2023-09-30 | $1.00K 10-Q · filed 2024-11-14 | $4.00K derived: sum of 2 quarters · filed 2024-11-14 | $5.00K 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $3.00K 10-Q · filed 2024-08-29 | $4.00K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |